Last reviewed · How we verify

intrarectal lidocaine gel — Competitive Intelligence Brief

intrarectal lidocaine gel (intrarectal lidocaine gel) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Gastroenterology.

marketed Local anesthetic Voltage-gated sodium channels Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

intrarectal lidocaine gel (intrarectal lidocaine gel) — Bagcilar Training and Research Hospital. Lidocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
intrarectal lidocaine gel TARGET intrarectal lidocaine gel Bagcilar Training and Research Hospital marketed Local anesthetic Voltage-gated sodium channels
Bupivacaine-fentanyl emergency group Bupivacaine-fentanyl emergency group Conrad Arnfinn Bjørshol marketed Local anesthetic + opioid analgesic combination Voltage-gated sodium channels (bupivacaine); mu opioid receptor (fentanyl)
Intra-articular Lidocaine Intra-articular Lidocaine University of Central Florida marketed Local anesthetic Voltage-gated sodium channels
Instillation - EXPAREL Instillation - EXPAREL Pacira Pharmaceuticals, Inc marketed Long-acting local anesthetic Voltage-gated sodium channels
isobaric mepivacaine isobaric mepivacaine Thomas Jefferson University marketed Local anesthetic (amide class) Voltage-gated sodium channels
Isobaric 2-chloroprocaine Isobaric 2-chloroprocaine Centre Hospitalier Universitaire Saint Pierre marketed Local anesthetic (ester) Voltage-gated sodium channels
Generic lamotrigine Generic lamotrigine University of Maryland, Baltimore marketed Anticonvulsant / Mood stabilizer Voltage-gated sodium channels; glutamate release inhibition

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). intrarectal lidocaine gel — Competitive Intelligence Brief. https://druglandscape.com/ci/intrarectal-lidocaine-gel. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: